OPS
CTXR icon

Orion Portfolio Solutions’s Citius Pharmaceuticals CTXR Stock Holding History

Orion Portfolio Solutions’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-144
Closed -$4K – 768
2020
Q2 		$4K Buy
+144
New +$3.15K ﹤0.01% 1534

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
WSTAM
Wilbanks Smith & Thomas Asset Management Norfolk, Virginia $3.57B AUM 21.11% 1-Year Est. Return
CHA
Cooper/Haims Advisors Victor, New York $212M AUM 12.19% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Orion Portfolio Solutions's CTXR Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of Citius Pharmaceuticals (CTXR) in Q3 2020, closing a stake of 144 shares — an estimated $4K sold.

Orion Portfolio Solutions first reported a position in CTXR in Q2 2020 and held it in 1 quarter. The position peaked at $4K in Q2 2020. 16 funds tracked by Wall St. Rank hold CTXR as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining Citius Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 144 Citius Pharmaceuticals shares in Q3 2020, an estimated $4K.
  • Orion Portfolio Solutions first reported a position in Citius Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Orion Portfolio Solutions's Citius Pharmaceuticals position peaked at $4K in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.